Balance Sheets - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Current Assets:
Cash	$ 461	$ 411,429
Prepaid expenses	95,182	40,182
Total current assets	95,643	451,611
Cash and marketable securities held in trust	17,876,466	70,456,287
TOTAL ASSETS	17,972,109	70,907,898
Current liabilities:
Accrued expenses	72,838	27,387
Amount due to Sponsor	384,050	84,500
Total Current Liabilities	456,888	111,887
Deferred underwriting compensation	690,000	690,000
TOTAL LIABILITIES	1,146,888	801,887
Commitments and contingencies (Note 7)
Ordinary shares subject to possible redemption, 1,652,509 and 6,900,000 shares (at redemption price of $10.82 and $10.21 per share) at December 31, 2025 and 2024, respectively	17,876,466	70,456,287
Shareholders’ deficit:
Ordinary shares, par value $0.0001 per share; 500,000,000 shares authorized; 2,000,900 and 2,000,900 shares issued and outstanding at December 31, 2025 and 2024, respectively	200	200
Additional paid-in capital
Accumulated deficit	(1,051,445)	(350,476)
Total Shareholders’ deficit	(1,051,245)	(350,276)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	$ 17,972,109	$ 70,907,898

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.